Loading…
CIK 0001822947 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("ally-bridge-group-ny-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $16.7M | 14.7% | 125,000 SH | New |
| ALUMIS INC | COM | $2.2M | 1.9% | 76,459 SH | New |
| AN2 THERAPEUTICS INC | COM | $2.5M | 2.3% | 526,315 SH | New |
| ASSEMBLY BIOSCIENCES INC | COM NEW | $3.8M | 3.4% | 140,000 SH | New |
| AVALO THERAPEUTICS INC | SPONSORED ADS | $2.8M | 2.5% | 150,000 SH | New |
| AXSOME THERAPEUTICS INC | COM | $4.0M | 3.6% | 16,493 SH | New |
| CLIMB BIO INC | COM | $3.2M | 2.9% | 249,172 SH | New |
| CYTOMX THERAPEUTICS INC. | COM | $2.9M | 2.6% | 775,000 SH | New |
| DEFINIUM THERAPEUTICS INC | COM SHS | $18.8M | 16.6% | 400,000 SH | New |
| EDGEWISE THERAPEUTICS INC | COM | $3.4M | 3.0% | 83,300 SH | New |
| EUPRAXIA PHARMACEUTICALS INC | COM | $1.7M | 1.5% | 252,175 SH | New |
| FIRST TRACKS BIOTHERAPEUTICS | ORD SHS | $5.7M | 5.1% | 284,287 SH | New |
| IBIO INC | COM NEW | $683K | 0.6% | 390,147 SH | New |
| IDEAYA BIOSCIENCES INC | COM | $2.5M | 2.2% | 67,500 SH | New |
| INVENTIVA SA | ADS | $2.4M | 2.1% | 634,800 SH | New |
| KURA ONCOLOGY INC | COM | $3.2M | 2.8% | 290,000 SH | New |
| MINERVA NEUROSCIENCES INC | COM NEW | $12.1M | 10.7% | 2,175,802 SH | New |
| OVID THERAPEUTICS INC | COM | $1.7M | 1.5% | 624,561 SH | New |
| PALISADE BIO INC | COM | $2.6M | 2.3% | 1,229,000 SH | New |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | $2.5M | 2.2% | 743,958 SH | New |
| PROMIS NEUROSCIENCES INC | COM SHS | $8.2M | 7.2% | 620,319 SH | New |
| SOLID BIOSCIENCES INC | COM | $2.6M | 2.3% | 255,959 SH | New |
| TRAWS PHARMA INC | COM | $663K | 0.6% | 786,236 SH | New |
| UROGEN PHARMA LTD | COM | $2.5M | 2.3% | 69,183 SH | New |
| WHITEHAWK THERAPEUTICS INC | COM | $3.7M | 3.3%Prev: 1.3% | 817,939 SH | Increased |
| 13F-HR |
| 0001193125-26-352338 |
| $113.1M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000950123-25-008419 | $120.2M | View |
| May 18, 2026 | Q1 2026 | 13F-HR | 0001193125-26-227559 | $123.8M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000950123-25-005586 | $110.9M | View |